Table 2 General characteristics of populations and study locations discussed in 118 articles on screening, diagnostics, and treatment of hepatitis C in Canada
Population Characteristic | Number of Articlesa | Percentage of Articles | ||
|---|---|---|---|---|
Type of Population | Vulnerable Populations | Persons who use injection drugs (PWID) | 35 | 29.6 |
At-risk youth | 8 | 6.7 | ||
Prison populations | 7 | 5.9 | ||
Indigenous people | 7 | 5.9 | ||
Non-vulnerable populations | Baby boomersb | 11 | 9.3 | |
Blood transfusion recipientsc | 11 | 9.3 | ||
General patient population | 39 | 33.1 | ||
Study Location | General Location | Inner City | 12 | 10.2 |
Urban | 8 | 6.8 | ||
Rural | 4 | 3.4 | ||
Specific Study Location | Clinic | 18 | 15.3 | |
Prison | 10 | 8.5 | ||
Community health centre | 5 | 4.2 | ||
Not specified | 61 | 51.7 | ||